IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016).    Offical Sponser for International Conference in malaysia ,  https://www.icmhas.com/

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
REGULATORY REQUIREMENTS AND APPROVAL PROCESS FOR MEDICAL DEVICE IN JAPAN, AUSTRALIA AND BRAZIL

Author: SRIDHAR S, BALAMURALIDARA V*, RAVEENA NAIR, ABHISHEK B V
Abstract: Medical Device is the one of the biggest and fastest growing market in the healthcare industry and marketing the medical device in the country requires it specific regulatory requirements and approval process. The regulatory requirements and evaluation of the device depends upon which class of medical device does it belongs to. So the classification of medical device also varies with country to country. Most of the countries define the classification as per the risk based classification and the requirement of the device also depends upon the class-lower risk of device & lesser the documents required. If the risk of the device increases the data like clinical investigation and evaluation requirement for the approval also increase the approval time. So there should be mandatory i.e., post marketing surveillance should be done by the manufacturer to study the adverse events. Main goal is intend to learn about the data requirement and the regulatory approval process of the medical device in selected regions like Japan, Australia and Brazil
Keyword: Medical Device, Regulatory requirements, Post Marketing Surveillance
EOI: http://eoi.citefactor.org/10.11209/ijpr.10.03
DOI: https://doi.org/10.31838/ijpr/2018.10.03.057
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477